Randomized, Prospective Comparison of the Outcome of Toric Implantable Contact Lens (TICL) and Q-LASIK for the Correction of Myopia With Astigmatism
The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2009 by Wenzhou Medical College.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Wenzhou Medical College
Collaborator:
STAAR Surgical
Information provided by:
Wenzhou Medical College
ClinicalTrials.gov Identifier:
NCT01088568
First received: March 16, 2010
Last updated: NA
Last verified: October 2009
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The objective is to conduct a contralateral prospective clinical study to compare the safety, efficacy, and quality of vision of the STAAR Surgical Co. Toric Implantable Contact Lens TICL) versus Custom Laser Vision Correction (Q-LASIK) in human eyes for the correction of myopia with astigmatism.
| Condition | Intervention |
|---|---|
|
Myopia Astigmatism |
Procedure: the implantation of toric implantable collamer lens Procedure: customized laser-assisted in situ keratomileusis |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Randomized, Prospective Comparison of the Outcome of TICL and Q Value Customized LASIK for the Correction of Myopia With Astigmatism |
Resource links provided by NLM:
Further study details as provided by Wenzhou Medical College:
Primary Outcome Measures:
- Comparing the efficacy, predictability, stability and safety of TICL versus Q-LASIK [ Time Frame: 1week, 1,3,6 months ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
- Comparing wavefront aberrometry of TICL vs Q-LASIK Comparing contrast sensitivity of TICL vs Q-LASIK Comparing patient satisfaction of TICL vs Q-LASIK [ Time Frame: 1, 3, 6 months ] [ Designated as safety issue: Yes ]
| Enrollment: | 30 |
| Study Start Date: | November 2007 |
| Estimated Study Completion Date: | March 2010 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: TICL group |
Procedure: the implantation of toric implantable collamer lens
perform the implantation of toric implantable collamer lens for both eyes
Other Name: TICL
|
| Active Comparator: LASIK group |
Procedure: customized laser-assisted in situ keratomileusis
perform Q-factor customized laser-assisted in situ keratomileusis for both eyes
Other Name: Q-factor customized LASIK
|
Eligibility| Ages Eligible for Study: | 21 Years to 45 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Age: 21-45 years old
- Documented stable refraction for at least 1 year
- (-3.0 to -8.0D of myopia with -1.0 to -4.0D of astigmatism or SE from -3.5 to -10D
- BSCVA: 20/20 or better
- Pupil diameter: smaller than 7mm under mesopic condition
- Contact lens discontinued 3 weeks and 1 week for hard and soft wearers respectively
Exclusion Criteria:
- Evidence of progressive or acute disease
- Evidence of connective tissue disease or clinically significant atopic disease
- ACD less than 2.8mm from endothelium
- ECC less than 2200 cells/mm2
- Narrow angle of anterior chamber
- Residual stromal thickness less than 280 microns
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01088568
Locations
| China, Zhejiang | |
| Eye hospital of Wenzhou Medical College | |
| Wenzhou, Zhejiang, China, 325027 | |
Sponsors and Collaborators
Wenzhou Medical College
STAAR Surgical
Investigators
| Study Director: | Qin Mei Wang | Eye hospital of Wenzhou Medical College |
More Information
Publications:
| Responsible Party: | Qinmei Wang MD, Eye hospital of Wenzhou Medical College |
| ClinicalTrials.gov Identifier: | NCT01088568 History of Changes |
| Other Study ID Numbers: | 20091231 |
| Study First Received: | March 16, 2010 |
| Last Updated: | March 16, 2010 |
| Health Authority: | China: Food and Drug Administration |
Keywords provided by Wenzhou Medical College:
|
Keratomileusis, laser in situ Phakic Intraocular Lenses myopia astigmatism Implantable Collamer Lens, Toric |
Additional relevant MeSH terms:
|
Astigmatism Myopia Refractive Errors Eye Diseases |
ClinicalTrials.gov processed this record on May 19, 2013